Intravenous immunoglobulin as immuno-modifying treatment
Publisher
Birkhäuser Basel
Reference147 articles.
1. Newburger JW, Takahashi M, Burns JC et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315 (6): 341–347
2. Hagen EC, Daha MR, Hermans J et al (1998) Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 53 (3): 743–753
3. Cohen Tervaert JW, Popa ER, Bos NA (1999) The role of superantigens in vasculitis. Curr Opin Rheumatol 11 (1): 24–33
4. Finkel TH, Torok TJ, Ferguson PJ et al (1994) Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343 (8908): 1255–1258
5. Bos OJ, Sunye DG, Nieuweboer CE, van Engelenburg FA, Schuitemaker H, Over J (1998) Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process. Biologicals 26 (4): 267–276